Pharma's Top 10 Efforts in Social Media
Upcoming SlideShare
Loading in...5
×
 

Pharma's Top 10 Efforts in Social Media

on

  • 2,054 views

 

Statistics

Views

Total Views
2,054
Views on SlideShare
1,196
Embed Views
858

Actions

Likes
0
Downloads
74
Comments
0

13 Embeds 858

http://www.medicinman.net 685
http://indianmedicinman.blogspot.in 92
http://indianmedicinman.blogspot.com 31
http://indianmedicinman.blogspot.de 14
http://indianmedicinman.blogspot.sg 11
http://www.indianmedicinman.blogspot.in 10
http://www.mobilephoneemulator.com 5
http://7294452752189663593_e9532f7a06a23e2ca70d5e1e9fcbbb2bff525bcc.blogspot.com 5
http://feeds.feedburner.com 1
http://www.medicinman.net&_=1349029365343 HTTP 1
http://indianmedicinman.blogspot.ch 1
http://www.medicinman.net&_=1349029295796 HTTP 1
http://indianmedicinman.blogspot.ca 1
More...

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Pharma's Top 10 Efforts in Social Media Pharma's Top 10 Efforts in Social Media Presentation Transcript

  • Pharma’s Top 10 Effortsin Social Media JD Lasica Socialmedia.biz jd@socialmedia.biz
  • Top 10 Pharma efforts J&J Glaxo-Smith-Kline Bayer Sanofi-Aventis Novartis AstraZenecaUS Bristol-Myers Squibb Roche Pfizer Boehringer Ingelheim
  • 1. Johnson & Johnson
  • Johnson & JohnsonHundreds of reader comments on JNJ BTW& Kilmer house blogs since 2007. (# ofadverse events reported: 0 )J&J purchased the online communityChildren With Diabetes in 2008 for areported $6-7 million.90+ videos on YouTube channel. Rob Haper, Marc Monseau director of corporateJ&Js director of video communications, communicationsproduces videos with human interest angle.Its division Ortho-McNeil-Janssen launchedthe ADHD Moms community on Facebook.Active Twitter presence with 2,120 followers.Twitter grade: B
  • Johnson & Johnson Children with Diabetes The online community’s goal is to promote understanding of the care and treatment of diabetes, especially in children; to increase awareness of the need for unrestricted diabetes care for children at school and daycare; to support families living with diabetes; and to promote understanding of research into a cure.
  • Johnson & Johnson Mom-bassadors McNeil Pediatrics, a division of Ortho-McNeil- Janssen, selects Mom-bassadors -- women who are passionately committed to ADHD care giving. Here they share their experiences in how they have helped care for, celebrate and support their children to overcome the daily challenges of ADHD year-round.
  • 2. Glaxo-Smith-Kline
  • Glaxo-Smith-Kline Glaxo-Smith-Kline’s alliConnect is the official corporate blog for alli, the only FDA-approved OTC weight loss product. Also, allicircles at http:// community.myalli.com/ is a support community.
  • Glaxo-Smith-Kline The GSK blog More Than Medicine says it is “expressly uninterested in promoting GSK brands” and will focus on creating a dialogue about the pressing issues facing the healthcare industry in the U.S., says Michael Fleming, senior director of social media at GSK. Modest YouTube channel with 12 videos. Modest Facebook presence, with 644 members and 30 wall posts On Twitter, @GSKUS has 1,485 followers, Twitter grade: B
  • 3. Bayer
  • Bayer
  • Bayer Didget is a  new social network and blood glucose monitoring tool for young people living with diabetes in the United Kingdom. The network connects directly into each participating youths Nintendo DS and rewards the user for building consistent blood glucose testing habits and meeting glucose targets.  Bayer also sponsors MSGateway, a patient community for patients with MS. It has 12,000-plus members, 200,000+ posts and has led to increased global sales of Betaferon. Similarly, myMSmyWAY is a collaboration between Bayer Healthcare, Microsoft and the National MS society. Bayer developed the Living with Hemophilia website to share some practical tools and strategies for living with hemophilia. Bayer on Twitter: German only; 239 followers; protects their tweets. Twitter grade: F
  • 4. Sanofi-Aventis
  • Sanofi-Aventis On May 15, Paris-based Sanofi-Aventis launched Sanofi- aventis.tv, an interactive video news site as part of its global effort to increase transparency and understanding of the pharmaceutical companys operations. Geoffroy Bessaud, head of corporate communications, said the site is an extension of the company-wide initiative to transform Sanofi- Aventis into a global healthcare leader. “We are setting up new tools for communicating, within the company and outside of the company,” he said. “The Web TV site is part of that.” The site has six themed channels to reach different stakeholder groups, including patients, healthcare professionals, employees, media, financial analysts and shareholders. It is available in English and French. SanofiaventisTV is just beginning a Twitter presence, with 496 followers. Oddly, posts are in English & French, instead of separate Twitter channels. Twitter grade: C
  • 5. Novartis
  • Novartis Novartis has developed CML Earth, a social network that connects Chronic Myeloid Leukemia patients. The site welcomes patients, patient groups and healthcare professionals from around the world. Facebook fan page with 2,183 fans, but no consistent presence there. No YouTube presence. Mediocre presence on Twitter: 3,038 followers; no personality; used as broadcast mechanism. NovartisTrials has 358 followers. Twitter grade: C-
  • 6. AstraZenecaUS
  • AstraZenecaUS AstraZenecaUS has created My Asthma Story, a stand- alone website accompanied by a YouTube channel around its product Symbicort. The company uses the site and YouTube channel to drive its audiences bi-directionally. On this channel, viewers hear stories from ordinary people coping with the challenges of asthma. It then demonstrates how Symbicort becomes an integral part of their regimen to manage asthma. Poor use of Twitter: all of its tweets are outgoing, one-way communications. 1,780 followers. Twitter grade: D Almost no Facebook presence: fan page with 121 fans and no updates.
  • 7. Bristol-Myers Squibb
  • Bristol-Myers Squibb In September 2008, Bristol-Myers Squibb launched the Advanced Breast Cancer Community, an information source and online community for advanced (metastatic) breast cancer patients, caregivers, family and friends. AdvancedBreastCancerCommunity.org represents the collective thinking of a partnership among 13 of the leading breast cancer patient advocacy organizations in the United States, The Advocate Partners and Inspire. This website changes to reflect new research, treatment and clinical trials information. No presence on Twitter other than an empty bmsinfo page. Facebook group has 394 members, 37 wall posts, 22 photos.
  • 8. Roche
  • RocheOn July 22-23, 2009, Roche Diabetes Care invited 29 diabetesspecialists and bloggers to a Social Media Summit. Workshopshelped Roche to ‘listen and learn’ from the opinions & input of others.The goal was to help bloggers/online advocates craft a manifesto forworking together in the interest of the patient community, and to spuran open discussion about Pharma’s engagement in diabetes socialmedia, including best practices.One output of the conference: a centralized web directory of alldiabetes resources, so that patients and doctors would have toremember only a single URL.A second output: patient messaging, with prominent patientsconnecting more closely with mainstream media to get the word outand help change the image of diabetes to something more positive.No Facebook or YouTube presence.Roche_com has 1,920 Twitter followers. Twitter grade: B
  • 9. Pfizer
  • Pfizer Pfizer is launching its first social networking initiative by teaming up with Private Access. The social network will bring together patients and clinical trial researchers. Once the site goes live, patients will have the opportunity to confidentially post personal health information that will be made available only to researchers studying their particular condition. Trial sponsors can use the network to recruit patients; patients will be able to learn more about the studies that relate directly to them. Almost no Facebook presence: fan page with 1,880 fans and no updates. No YouTube channel. @pfizer_news has 2,371 followers. Strictly one-way communication. Twitter grade: C-
  • 10. Boehringer Ingelheim
  • Boehringer Ingelheim Germany-based Boehringer Ingelheim is making smart use of Twitter, using it to post not just company information but to recommend health- related articles and information. Twitter grade: A- John Pugh, who handles BI’s Twitter account, John Pugh says 70% of his job responsibilities involve social director of global corporate media and the development of the companys communications presence in these new channels. Facebook group with 1,200 members, 85 wall posts, 21 posts.
  • However ...While there are a handful of other social media efforts inthe marketplace, Pharma remains well behind the curvein social media compared to other sectors such as tech,cable, retail, sports, even autos. Regulation should notbe used as an excuse for failing to engage.
  • CSR: A missed opportunity One area rich with possibility: Using social media to bring greater awareness to corporate social responsibility efforts. But few pharma companies are doing so. Good CSR focuses on both bottom line and public good. It extends beyond marketing to tie into strategic business objectives. CSR extends to internal and external constituents, focusing on building global brand, employee attraction & retention, client and partner attraction & retention. Campaigns should be tied to Internet-enabled one-to-one gifting. See DonorsChoose, Kiva, UniversalGiving.
  • Thank you! JD Lasica Founder, Socialmedia.biz email: jd@socialmedia.biz Twitter: @jdlasica Sources: • http://www.doseofdigital.com/healthcare-pharma-social-media-wiki/ • Ron Callari, InventorSpot.com • Original research